Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 15, 1999

View Archived Issues

UK Vows To Hold Off Germany, Others As Top Biotech Country

Genetics Of Rare Syndrome Offer Clues To Periodontitis

NeuroSearch Raises DKK 97M For Cell Transplant Spin-Off

Flamel, Novo Nordisk Team Up In Deal For Insulin Formulation

Powderject Faces Two-Year Delay In Marketing Of Lead Product

Ibex Trims Operations To Save Money While Seeking Partner

Bionomics Close To Listing Through IPO In Australia

Peptech Offers Stock To Buy Sydney Company For $41M

XTL, AVI Agree To Collaborate On Therapeutics For Hepatitis

Transghnes Gene Therapy Shows Promise In Phase II

Cantab Boosts HSV Position In Licensing Deal With GenVec

Israel, California Agree To Work Together On Biotech Initiatives

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...